The Diagnostic Journey in Extrapulmonary Neuroendocrine Carcinoma: Team-Based Care and Classification

In this episode, 'The Diagnostic Journey in Extrapulmonary Neuroendocrine Carcinoma: Team-Based Care and Classification,' the expert oncologists explored the following questions:

How is extrapulmonary neuroendocrine carcinoma diagnosed and which specialties are involved?

How does the patient navigate this diagnosis once it is received?

Who is involved in care?

What does cost look like once diagnosed in terms of imaging and treatments?

How are pathologists characterizing extrapulmonary neuroendocrine carcinomas?

Are there classification systems that are useful?

The panelists examined the multidisciplinary nature of extrapulmonary neuroendocrine carcinoma (epNEC) diagnosis, noting that the specialties involved — including gastroenterology, urology, gynecologic oncology, and interventional radiology — vary depending on the primary tumor site, with pathology serving as the unifying cornerstone across all cases. William Oh, Aman Chauhan, Namrata Vijayvergia, and Sandy Kotiah discussed how patients often present urgently, requiring rapid coordination of care and immediate treatment planning, while also facing significant emotional and financial burdens throughout their journey. The panelists highlighted the importance of patient support groups, access to clinical trials, and guidance from knowledgeable medical oncologists in navigating ongoing treatment decisions. They also addressed how pathologists characterize epNEC, emphasizing the importance of differentiation status and Ki-67 index in guiding treatment, while acknowledging that the term "extrapulmonary neuroendocrine carcinoma" is relatively new and that classification continues to evolve.

Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

The next episode in this series, 'Closing the Gap: Underrecognition and the Critical Need for Early Diagnosis in Extrapulmonary Neuroendocrine Carcinoma,' features the panelists advancing their conversation on extrapulmonary neuroendocrine carcinoma and focusing on the underrecognition of epNEC in clinical practice and why early diagnosis is critical for improving patient outcomes.